I tend to only use this strategy to a great extent when I have a negative or neutral view on the overall market.
There are reasons to believe the shares of Dynavax Technologies and Eyenovia Inc. could do well in the months ahead.
This stock has been providing me with a nice 'synthetic' dividend stream for years.
A recent trio of acquisition deals indicates the doldrums in the sector may be over.
Let's review the charts and indicators.
There was a lot of reaction to the Ginkgo Bioworks Holdings short report on Twitter Wednesday not too long after it was published.
A double in five months has my attention.
Let's take a look at the charts and indicators.
There was over $2 million in insider buying earlier in the year so management appears to be optimistic.
Ginkgo Bioworks has great potential for science and investors.